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Seasonally recurrent influenza virus infections are a significant cause of global morbidity
and mortality. In murine models, primary influenza infection in the respiratory tract elicits
potent humoral responses concentrated in the draining mediastinal lymph node and the
spleen. In addition to immunity within secondary lymphoid organs (SLO), pulmonary
infection is also associated with formation of ectopic inducible bronchus-associated
tissues (iBALT) in the lung. These structures display a lymphoid organization, but their
function and protective benefits remain unclear. Here we examined the phenotype,
transcriptional profile and antigen specificity of B cell populations forming iBALT in
influenza infected mice. We show that the cellular composition of iBALT was comparable
to SLO, containing populations of follicular dendritic cells (FDC), T-follicular helper (Tfh)
cells, and germinal center (GC)-like B cells with classical dark- and light-zone polarization.
Transcriptional profiles of GC B cells in iBALT and SLO were conserved regardless of
anatomical localization. The architecture of iBALT was pleiomorphic and less structurally
defined than SLO. Nevertheless, we show that GC-like structures within iBALT serve as a
distinct niche that independently support the maturation and selection of B cells primarily
targeted against the influenza virus nucleoprotein. Our findings suggest that iBALT, which
are positioned at the frontline of the lung mucosa, drive long-lived, and unique GC
reactions that contribute to the diversity of the humoral response targeting influenza.
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INTRODUCTION
The generation of adaptive immune responses to infection requires the complex and elegant
coordination of T and B lymphocytes, concentrated within secondary lymphoid organs (SLO), such
as the spleen and lymph nodes. SLO are highly organized and regulated structures, facilitating
antigen concentration, capture and presentation to naïve lymphocytes, thereby facilitating the
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activation, and differentiation of T and B cells into effector
populations. Further specialized zones of germinal centers (GC)
drive maturation of the humoral response via the selection of
high affinity antibodies, providing an effective source of long-
lived protection in the form of serum antibody and antigen-
experienced memory B and T cell populations.
While SLO develop during embryogenesis at discrete
anatomical locations (1), the induction of immunological
structures resembling SLO has been reported at peripheral sites
in response to inflammatory stimuli or infection with pathogenic
microorganisms (2–5). Variably described as ectoptic lymphoid
tissue or tertiary lymphoid organs, such lymphocyte aggregations
also tend to form proximal to the bronchi within the lung and are
termed inducible bronchus-associated lymphoid tissues (iBALT).
Induction of iBALT has been extensively reported following
pulmonary infections by bacterial (6, 7) or viral agents (8–10).
iBALT can also form in response to exposure to particulates (11,
12) or pro-inflammatory mediators (13, 14), and chronic allergic
or inflammatory diseases such as COPD and asthma (15). Despite
conservation across numerous species and a wide number of
contexts, the contribution of iBALT to humoral immunity against
influenza is not fully understood.
While it is unlikely that a single pathway for iBALT
genesis exists given the wide range of originating stimuli, the
developmental models proposed for ectoptic lymphoid tissues
have commonalities (16). Based on these models, cytokine and
chemokine production from innate cells such as ILCs and
γδT cells recruit pro-inflammatory granulocyte populations,
which in turn drive the CXCL13-dependent recruitment of
mature B cells into the lung (14, 17–19). Similar to the
maintenance of conventional lymphoid tissues, T and B cells
support the differentiation of stromal cells into mature follicular
dendritic cells (FDC) and fibroblastic reticular cells (FRC),
with homeostatic maintenance allowing these lymphoid-like
structures to persist for months in the absence of ongoing
inflammation or infection (20–22). While iBALT is decidedly
pleiomorphic (16), several groups have reported the presence
of B-cell clusters, networks of FDC, T cell areas, and zones
resembling germinal centers, with iBALT supporting the
proliferation of both B and T cells (8–10, 13, 23). Notably,
iBALT can initiate protective humoral and T cell responses
following influenza infection in mice lacking SLO (8, 9),
although the relative importance of lung-generated responses in
immunocompetent animals is unclear.
Using the influenza infection model in mice, we sought to
address two questions. First, to what extent do the GC-like
structures in the lung resemble GC in SLO? In particular, do
iBALT GC-like structures facilitate B cell selection and affinity
maturation? Second, to what extent is the lung a priming
site for humoral immunity to pulmonary influenza infection
in immunocompetent animals? We show GC responses in
influenza infection-induced iBALT were comparable to GC
in SLO in terms of cellular composition, phenotype, and
transcriptional profile. However, the architecture of iBALT
GC was non-classical, lacking discrete light and dark zone
polarization and T cell compartmentalization to the light zone.
Nevertheless, using labeled recombinant influenza antigens
to probe B cell specificities, we find that influenza-specific
GC responses within iBALT predominantly targeted the viral
nucleoprotein, constituted a unique clonal repertoire relative to
SLO, and demonstrated a comparable capacity to drive somatic
mutagenesis and B cell selection requisite for affinity maturation.
Our work has implications for the development of improved
humoral immunity to influenza by establishing long-lived and
unique GC reactions at the frontline of the lung mucosa.
MATERIALS AND METHODS
Animal Infection
All animal procedures were approved by the University
of Melbourne Animal Ethics Committee. C57BL/6 mice at
6–10 weeks of age were used. Mice were anesthetized
by isoflurane inhalation prior to infection. For intranasal
infections, mice were instilled with 50 µL volume of 50
TCID50 of A/Puerto Rico/8/34 (PR8).
Confocal Microscopy
Fresh tissues were snap-frozen in O.C.T. compound (Sakura
Finetek USA) and stored at −80◦C. Tissues were sectioned at
7µm thickness (Leica). Prior to staining, sectioned tissues were
fixed in cold acetone solution (Sigma) for 10min then rehydrated
with PBS for 10min and blocked with 5% (w/v) bovine serum
albumin (Sigma) and 2% (v/v) normal goat serum (NGS).
Cell staining was performed using the following antibodies:
IgD (11-26c.2a; Biolegend), B220 (RA3-6B2; BD), GL7 (GL7;
Biolegend), CD35 (8C12; BD), CD3 (17A2; Biolegend), CD169
(3D6.112; BD), CD86 (GL1, Biolegend), CXCR4 (2B11; BD),
CD4 (GK1.5; Biolegend), Ki67 (11F6, Biolegend), BCL6 (K112-
91; BD). To amplify the CXCR4-PE signal, tissues were stained
sequentially with rabbit anti-PE antibody (polyclonal; Novus
Biologicals) and a secondary goat anti-rabbit IgG Alexa Fluor
555 antibody (polyclonal; Life Technologies). Slides were sealed
with ProLong Diamond Antifade Mountant (Life Technologies).
Tiled Z-stack images covering were captured on a Zeiss LSM710
microscope. Post-processing of confocal images was performed
with ImageJ v2.0.0.
HA Proteins
Recombinant HA protein for use as flow cytometry probes
was derived for A/Puerto Rico/08/1934 as previously described
(24). Briefly, expression constructs were synthesized (GeneArt)
and cloned into mammalian expression vectors. Proteins
were expressed by transient transfection of Expi293 (Life
Technologies) suspension cultures and purified by polyhistidine-
tag affinity chromatography and gel filtration. Proteins were
biotinylated using BirA (Avidity) and stored at −80◦C.
Prior to use, biotinylated HA proteins were labeled by the
sequential addition of streptavidin (SA) conjugated to BV421,
phycoerythrin (PE), or allophycocyanin (APC), and stored at
4◦C. Recombinant influenza A H1N1 NP protein (11675-V08B;
Sino Biological) was labeled with PE or APC fluorochromes using
commercial conjugation kits, as per manufacturer’s protocol
(AB102918, AB 201807; Abcam).
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Flow Cytometry
For experiments requiring discrimination of blood and tissue
populations, mice were intravenously labeled with 3 µg of
CD45.2 antibody (104; eBioscience) in a 200 µL volume prior
to tissue collection. Tissues were mechanically homogenized
into single cell suspensions in RF10 media (RPMI 1640, 10%
FCS, 1 × penicillin-streptomycin-glutamine; Life Technologies).
Except for MLN, red blood cell lysis was performed with
Pharm LyseTM (BD). Isolated cells were Fc-blocked with a
CD16/32 antibody (93; Biolegend). For all B cell experiments,
cells were surface stained with Live/dead Aqua viability dye
(Thermofisher) and B220 (RA3-6B2; BD), IgD (11-26c.2a;
BD), CD45 (30-F11, BD), GL7 (GL7; Biolegend), CD38 (90;
Biolegend), Streptavidin (BD), CD3 (145-2C11; Biolegend),
and F4/80 (BM8; Biolegend). For LZ/DZ experiments cells
were also stained with CD86 (GL1, Biolegend) and CXCR4
(2B11; BD). Antigen-specific B cells were detected based
upon dual staining with HA or NP probes conjugated to
APC and PE. For Tfh cell characterization, cells were stained
in Transcription Factor Buffer Set (BD) with Live/dead
Red viability dye (Life Technologies), BCL6 (IG191E/A8;
Biolegend), CD3 (145-2C11; Biolegend), PD-1 (29F.1A12;
Biolegend), CXCR5 (L138D7; Biolegend), CD4 (RM4-5; BD),
B220 (RA3-6B2; BD), and F4/80 (T45-2342; BD). Stained
cells were washed twice and fixed with 1% formaldehyde
(Polysciences) for acquisition on a BD LSR Fortessa, or
resuspended in Optimem (Life Technologies) for sorting on a
BD FACSAria III.
RNAseq and Data Analysis
Single cell suspensions were processed and stained as described
above. Memory B cells (B220+ IgD- CD38hi GL7-), GC
B cells (B220+ IgD- CD38lo GL7+), and T cells (CD3+)
were sorted into RLT buffer (Qiagen) containing 0.14M
β-mercaptoethanol (Sigma). Post-sort, cells were suspended
in a volume of RLT buffer representing 3.5x the sorting
solution volume. Genomic DNA was removed using a gDNA
eliminator (Qiagen), according the manufacturer’s protocol.
RNA was extracted by addition of 100% ethanol in a 5:7
volume ratio to flow-through solution and processed with
the RNeasy Plus Micro Kit (Qiagen), according to the
manufacturer’s instructions. The Australian Genome Research
Facility (Melbourne, Australia) performed the RNAseq with
an Illumina HiSeq 2500 and obtained 100bp single reads.
The library was prepared with a TruSeq Stranded mRNA
Library Prep Kit (Illumina). RNAseq analysis was performed
using the web-based Galaxy platform maintained by Melbourne
Bioinformatics (25). Reads were mapped to the Mus musculus
reference genome (mm10) using HISAT2 (26) and reads were
quantified using HTSeq (27). Count matrices were generated
and inputted into Degust (http://degust.erc.monash.edu) for
data analysis and visualization with the Voom/Limma method
selected for data processing. Heat maps were generated using
Morpheus (The Broad Institute; https://software.broadinstitute.
org/morpheus/). Raw sequence reads can be accessed with GEO
code: (GSE124369).
Sequencing and Analysis of Murine B Cell
Receptor Genes
Sequencing of murine heavy chain immunoglobulin sequences
was performed as previously described (28). Briefly, single B
cells stained with the panel above and NP-PE or HA-BV421
probes were sorted into 96-well plates and cDNA prepared
using SuperScript III Reverse Transcriptase (Life Technologies)
and random hexamer primers (Life Technologies). Heavy chain
immunoglobulin sequences were amplified by nested PCR using
HotStar Taq polymerase (Qiagen) and multiplex primers binding
V-gene leader sequences or the immunoglobulin constant
regions. PCR products were Sanger sequenced (Macrogen) and
VDJ recombination analyzed using High V-QUEST on IMGT
(29). Clonality was determined based upon shared gene usage and
CDR-H3 length and sequence similarity. Circular layout graphics
were generated using the Circlize package in R (30).
Statistics
Data are generally presented as the median ± interquartile
range or the mean ± SD. Flow data was analyzed in FlowJo v9
(FlowJo) and all statistical analyses were performed using Prism
v7 (GraphPad).
RESULTS
Dynamics of iBALT Induction Following
Intranasal Influenza Infection
To study lung B cell responses to influenza, we first performed
intranasal infection of mice with A/Puerto Rico/08/1934 (PR8)
virus. Consistent with previous reports (8, 10, 31, 32),
intranasal infection resulted in a pronounced infiltration of
B cells into the lung. Lung-infiltrating B cells, distinguished
from blood-circulating populations by intravenous CD45.2
labeling, displayed peak numbers 14 days (d14) post-infection
and persisted up to d112 (Figure 1A; gating Figure S1). A
subpopulation of B cells expressing a GC-like phenotype (B220+
IgD- GL7+ CD38lo) were evident in lungs at d14 post-
infection and detectable up to d112, albeit waning at the
latter timepoint (Figure 1B). In comparison, mediastinal LN
(MLN) displayed the largest proportion of GC B cells with
continued maintenance at high frequencies up to d112 post-
infection, in line with our previous observations (33). Splenic
GC B cells frequencies peaked at d14, rapidly waned and
was proportionally lowest amongst the tissues analyzed from
d28 onward.
When visualized using confocal microscopy, lung tissues
from infected mice similarly showed B cell infiltration and
clustering (Figure 1C). Although B cell infiltration was observed
at d7, cells were not structurally organized and were mostly
dispersed around the bronchi regions. GC-like structures,
demarcated by GL7 staining, were apparent at d14, peaking
in size between d28 and d56, and subsequently waning in
size by d112. When analyzed by flow cytometry, lung B
cells gradually acquired a canonical GC phenotype in later
timepoints, with full differentiation into GL7+ CD38lo and peak
absolute numbers of GC B cells observed by d35 (Figure S2).
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FIGURE 1 | iBALT formation and characterization following intranasal influenza infection in mice. (A) Lung B cell infiltration (B220+ intravenous (IV) CD45.2-) and (B)
frequency of GC B cells (B220+ IgD- CD38lo GL7+) across various tissues were measured in mice infected intranasally with A/Puerto Rico/08/1934. Data represent
two independent experiment (n = 6). Error bars represent mean ± SD. (C) Induction and maturation of iBALT across various time-points visualized by composite
images comprising B220 (orange), IgD (gray), GL7 (green), and CD35 (cyan); scale bar −100µM. (D) GC cellular composition of lungs and spleen visualized by
immunofluorescence staining at d35 post-infection; scale bar −50µM. (E) Frequency and (F) visualization of light- and dark-zone GC B cells in lungs and SLO at d35
post-infection. Data represent a single experiment (n = 6). Error bars represent mean ± SD. Scale bar −50 µM.
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As mature persistent GC responses are well-established in
both iBALT and the draining MLN by d35, we selected
this as a suitable timepoint for subsequent GC analysis. We
contrasted the structural characteristics of putative lung GC with
canonical splenic GC from infected mice at d35 post-infection
(Figure 1D). Despite a pleiomorphic appearance (Figure S3),
both FDC (CD35+) and highly clustered B cells (B220+)
expressing GL7 were detected in iBALT analogous to the
spleen. In contrast, T cells (CD3+) were dispersed throughout
the lung tissues and CD169 staining, which demarcates
subcapsular sinus macrophages in the spleen, was negligible in
iBALT structures.
GL7 expression in SLO is tightly linked to GC localization
(34). The distributed GL7 staining throughout iBALT led
us to question if the observed GC-like B cell structures
were functionally analogous to actual germinal centers. We
therefore examined the differential expression CXCR4 and CD86,
previously described for the delineation of dark- and light-zone
resident cells in both human and murine GC (35). GC B cells
from the lung displayed the characteristic differential expression
profiles of CXCR4 and CD86, analogous to staining in MLN
and spleen (Figure 1E). However, CXCR4 and CD86 staining
visualized by immunofluorescence microscopy on lung resident
B cell clusters was diffuse, lacking the discrete localization of
light- and dark-zone staining seen in splenic samples (Figure 1F).
Light and dark zone polarization requires differential chemokine
expression by stromal cells, including FDC (36). Compared
to the expected focused and GC-polarized FDC staining in
MLN and spleen, FDC staining within the lung was diffuse
with little indication of light-zone localization (Figure S4). Thus,
while GC-like structures within influenza-induced iBALT display
many phenotypic characteristics consistent with conventional
GC within SLO, they appear morphologically unconventional.
Transcriptional Profile of GC-Like B Cells
From iBALT
To facilitate an in-depth comparison of GC B cells from
different anatomical sites, memory and germinal center B cells
were sorted from the lung, spleen, MLN and blood of mice
at d35 post-infection (gating Figure S1), and differential gene
expression profiles were generated by RNASeq. Based upon
multi-dimensional scaling, iBALT GC-like B cells clustered
closely with GC B cells from SLO and were distinct from both
memory B cell populations and T cell controls (Figure 2A).
This was similarly evident within a heatmap generated using
the top 200 differentially expressed genes, where memory and
GC-like populations displayed discrete expression profiles across
lung-, MLN-, and spleen-localized cells (Figure 2B). Notably,
iBALT GC-like B cells, but not memory B cells, expressed the
master transcription factor bcl6, and canonical GC B cell markers
fas, aidca, gcsam, and s1pr2 in a manner comparable to GC B
cells from SLO (Figure 2C). Conversely, we observed limited
expression of genes associated with the memory phenotype in
GC B cell populations (ccr7, s1pr1, ly6d, cd38, sell). Consistent
with previous BrdU incorporation data (8), iBALTGC-like B cells
appeared to be proliferating (expressing ki67).
iBALT-Resident Tfh Cells Express Bcl6
and Ki67
Follicular T helper cells (Tfh) are critical for the generation and
maintenance of germinal centers in SLO (36), but the presence of
Tfh in lung iBALT induced by influenza infection is understudied.
We found comparable frequencies of Tfh cells (CD3+ CD4+
CXCR5++ PD1++) were evident within the lungs and MLN
of mice at d35 and d56 post-infection, encompassing close to
10% of the total CD4+ T cell population (Figure 3A; gating
Figure S5A). Tfh from both MLN and lungs expressed elevated
levels of the lineage-defining transcription factor BCL6 (37,
38) compared to conventional CD4+ T cells (CXCR5- PD1-)
(Figure 3B), althoughwith higher comparative expression (based
upon fluorescence intensity) observed within MLN-derived Tfh
cells. Intracellular Ki67 expression suggested that lung Tfh cells
contained a similar proportion of recently proliferating cells
compared to MLN at d35, but marginally higher proliferation
than MLN Tfh cells at d56 (Figure 3C). B220+ cells expressing
high levels of Ki67 and BCL6 were also present in both lungs and
MLN of infected mice, although with frequencies higher in in the
latter tissue (Figure S5B).
Ki67 (Figure 3D) and BCL6 (Figure 3E) expression in spleen
and lungs of mice at d35 post-infection was visualized by
confocal microscopy. As expected, the spleen showed distinct
spatial segregation of T and B cell zones. In contrast, we found
CD4T cell and B cell clusters to be substantially smaller in the
lungs and their spatial segregation was not clearly delineated.
Mirroring expression measured by flow cytometry, Ki67 and
BCL6 expression were detected in B220 and CD4 cells of both
spleen and lungs, although expression of these markers was more
evident in B220 cells. Overall, while we observed differences in
anatomical localization, Tfh within iBALT-resident GC structures
appear phenotypically analogous to SLO-resident Tfh cells.
Specificity of GC-Resident B Cells for
Major Influenza Antigens
The antigen specificity of lung- or SLO-localized GC B cells
was analyzed using recombinant influenza HA and NP probes
(Figure 4A). NP-specific GC B cells were evident in all infected
mice at both d35 and d56 post-infection at all sites, whereas
HA-specific GC B cells were observed almost exclusively in the
MLN and spleen, with little to no HA-specific GC B cells in the
lungs (Figure 4B). In terms of absolute numbers of HA- and NP-
specific GC B cells at both timepoints, the majority of HA-specific
GC B cells were found in the MLN, a minor population in the
spleen, and little to no HA-specific GC B cells observed in the
lungs (Figure 4C). In contrast, NP-specific GC B cell were found
at high frequencies and counts in all tissues, withMLN and spleen
showing similar total cell counts while less cells were detected
in lungs.
GC Within iBALT Support Maturation of
Influenza-Specific B Cells
We next examined if iBALT GC structures display a functional
capacity to drive maturation of the influenza-specific B cell
response. NP- and HA-specific B cell populations were sorted
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FIGURE 2 | Transcriptional profile of GC-like B cells in iBALT. GC (B220+ IgD- GL7+ CD38lo) and memory B cells (B220+ IgD- GL7- CD38hi) were sorted from SLO
and iBALT in mice at d35 post-infection with PR8. mRNA expression profiles were compared using RNAseq data from 2 to 3 independent sequencing experiments.
(A) Multi-dimensional scaling plot showing clustering of memory and GC populations relative to T cell controls. (B) Heatmap of the top 200 differentially expressed
genes, with shading indicating expression relative to the average (red–overexpressed, blue–underexpressed). (C) Differential expression of selected genes previously
described to demarcate memory and GC subsets. Error bars represent mean ± SD.
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FIGURE 3 | Characterization of Tfh cells in iBALT. (A) Frequency of Tfh cells (CD3+ CD4+ CXCR5++ PD1++) in MLN and lungs of mice at d35 and d56
post-infection with PR8. (B) Intracellular BCL6 staining measured by mean fluorescence intensities in Tfh and non-Tfh CD4T cells (CD3+ CD4+ CXCR5- PD1-)
isolated from MLN and lungs. (C) Frequency of proliferation marker Ki67 expressed in Tfh and non-Tfh CD4T cells isolated from MLN and lungs. Data represent a
single experiment (n = 4–5). Error bars represent mean ± SD. Visualization by immunofluorescence microscopy of (D) Ki67 and (E) BCL6 expression in T and B cells
of spleen and lung iBALT; scale bar −50µM.
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FIGURE 4 | Antigen specificity of GC B cells in lung iBALT and SLO. (A) Representative HA and NP probe staining of GC B cells (B220+ IgD- CD38lo GL7+) isolated
from lung iBALT, MLN, and spleen of mice at d35 post-infection with PR8. (B) Frequency of HA-, NP-specific, and undefined GC B cells isolated from individual mice
at d35 and d56 post-infection. (C) Absolute counts of HA-specific and NP-specific GC B cells in lung iBALT, MLN, and spleen of mice at d35 and d56 post-infection.
Data represent two independent experiment (n = 4–5). Error bars represent mean ± SD.
from GC in the lung and MLN at d14, d35, and d56 and heavy
chain B cell receptor sequences were recovered, aligned and
grouped into clonal families. Antigen-specific B cell populations
in the lung (NP) and MLN (NP and HA) consisted of numerous
clonally-expanded lineages (Figure 5A), indicating proliferation
consistent with the observed Ki67 expression. We observed
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FIGURE 5 | BCR sequencing of GC B cells in the lung and mediastinal lymph node. Heavy chain immunoglobulin sequences were recovered from NP- and
HA-specific GC B cells sorted from the lung and mediastinal lymph nodes of PR8-infected mice on d14, d35, and d56. Data represents a single experiment with 5
mice per timepoint. (A) Circular plots detailing the clonal distribution of NP- and HA-specific populations from each site. Each segment represents a unique B cell
clonotype, the width proportional to the number of clonal family members recovered. Shared clonotypes between sites are indicated by the linking arcs. Number of
unique clonal families and BCR sequences are indicated below. (B) The degree of V-gene somatic mutation in recovered heavy chain immunoglobulin sequences from
each site. NP- and HA-specific B cells are indicated in blue and red, respectively. Error bars represent median ± interquartile range.
discrete compartmentalization of the humoral response, with
minimal sharing of clonotypes and different clonal hierarchies
seen between the lung and MLN, indicating B cell recruitment
to each of these sites was highly segregated. This pattern was
conserved across all animals and timepoints analyzed, and is
consistent with previous reports that the lung hosts a unique
B cell repertoire (39). The observed rates of V-gene somatic
mutation in the MLN were comparable for both NP- and HA-
specific GC B cells, increasing over time from a median 3.1% to
5.2% to 5.3% from d14 to d35 to d56 respectively (Figure 5B).
Similarly within the lung, while few HA-specific B cells were
recovered, somatic mutation in B cells that were mostly NP-
specific increased from 2.4% to 4.5% to 4.6% across the same
timepoints. Notably, the mutation load of influenza-specific GC
B cells within iBALT remained consistently lower (∼0.7%) in
comparison to theMLN at each timepoint sampled. However, the
rate at which somatic mutations accumulated was comparable to
the MLN suggesting an equivalent capacity to drive maturation
of humoral responses exists at both sites. Differences observed
between the tissues are likely due to the delayed biogenesis of
iBALT-localized GC.
DISCUSSION
There is considerable interest in the generation of local immunity
within the lungs to protect from influenza and other respiratory
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pathogens. iBALT represent a focus of lymphoid tissues that has
the potential to improve immunity within the lower respiratory
tract. Despite the iBALT being pleiomorphic and less structurally
defined than SLO GC structures, we found GC B cells in iBALT
and SLO were transcriptionally similar and show that iBALT
serve as a distinct anatomical niche for the maturation and
selection of B cells primarily targeted against the influenza
virus nucleoprotein.
The cellular composition of iBALT can vary, depending
upon the stimuli used for induction (16). Consistent with
previous reports, we observed cellular infiltration concentrated at
bronchial junctions that included FDC (8), Tfh and conventional
T cells (8, 9, 32), and germinal center B cell populations
(10) following pulmonary influenza infection. In contrast, LPS-
induced iBALT exhibits lung-infiltrating T cells with Tfh-like
function but lacking classical CXCR5/BCL6 expression (13).
Further, inoculation with LPS or whole Pseudomonas aeruginosa
bacteria results in ectopic lung GC structures that lack FDC,
in contrast to the CXCL13-expressing FDC observed following
infection with modified vaccinia virus Ankara (7, 13, 40).
Nuances in iBALT biogenesis appear attributable to the extent
and nature of inflammation induced by infectious diseases
compared to alternative pulmonary stimuli.
Germinal centers are highly specialized foci facilitating B
cell proliferation, competition, and selective differentiation
in order to drive high affinity serological antibody responses.
We find that clusters of GC-like B cells observed within
iBALT appear analogous to GC B cells in SLO with respect to
cellular composition and phenotype. This includes evidence of
proliferation, division into light- and dark-zone phenotypes,
expression of canonical GC transcription factors, and the
presence of Tfh cells. Here we extend previous studies
(8, 40) by transcriptional profiling lung GC-like B cells by
RNAseq. We found a conserved transcriptional signature
was shared by GC B cells independent of anatomical
location, with both lung- and SLO-resident populations
expressing canonical transcription factors (e.g., bcl6), mediators
of affinity maturation (e.g., aidca), and key chemotactic
factors (e.g., s1pr2).
One key area of difference between GC within SLO vs. iBALT
was the variant morphology, with a lack of highly distinct T
and B cell zones observed in iBALT consistent with previous
reports (8, 9, 41), and a lack of spatial segregation of B cells
phenotypically characteristic of light- and dark-zone B cells. The
impact of atypical GC architecture upon the development of B
cell immunity in the lung is unclear. Previous studies have shown
light- and dark-zone B cells exhibit largely overlapping gene
expression patterns (42). Experiments using CXCR4-deficient
mice (43) have established that B cells can cycle between these two
states, and that discrete light- and dark-zone architecture is not
a requisite for affinity maturation nor plasma cell differentiation
(44). Based upon recovered BCR sequences from GC-resident
B cells, we find GC in the lung maintain a capacity to drive
maturation of the influenza-specific B cell response, with the
continued accumulation of somatic mutations observed over
56 days post-infection. While overall mutation frequencies
were consistently higher in the draining MLN, the rate of
accumulation was comparable between the two sites suggesting
no detectable defect in the functionality of iBALT-localized GC.
Given the importance of anti-HA antibody for protection
against influenza (45), the contribution of iBALT to serological
HA-specific antibody seems minimal. Certainly, non-
neutralizing antibody responses, such as those targeting
NP, can contribute to immunity via Fc-mediated functions or
antibody-dependent cellular cytotoxicity, and further provide
protection against heterosubtypic influenza virus challenge
in mice (46–50). iBALT might conceivably act as a source of
mucosal-resident antibody-secreting cells (ASCs) that contribute
to ongoing barrier protection in the lung. We observed strong
compartmentalization of B cell receptor repertoires within
anatomical sites, implying that alternative B cell clonotypes are
recruited to and maintained in lung GC compared to SLO. This
additional clonotypic diversity may be advantageous during
recurrent exposure to antigenically diverse pathogens such
as influenza. The extended persistence of iBALT, reported for
up to 3 months (9, 10, 31, 40), may also serve as a broader
niche to position B cells proximal to a site of recent mucosal
barrier damage. Interestingly, we find a significant proportion of
lung-resident GL7+ B cells, comprising up to half of total cells,
were of undefined specificity. This corroborates previous studies
demonstrating that the iBALT can act as a general priming site,
thus supporting the proliferation of GC B cells binding antigens
unrelated to the primary inducing agent (23, 51). While these GC
B cells may also simply represent B cells specific for alternative
antigenic targets of the influenza virus not captured by our
probes (52), or non-specific bystander B cells adopting a GC
phenotype, they may also be elicited by antigenic translocation
of microorganisms as a result of lung damage during infection.
Additional definition of the specificities of iBALT-resident GC B
cells is warranted.
In summary we find GC-like structures in iBALT are
phenotypically, transcriptionally and functionally comparable
to those within SLO, yet recruit a distinct subset of B
cell clonotypes into the humoral immune response. While
iBALT can drive B cell diversification and may facilitate
residence of B and T lymphocytes proximal to the mucosa,
the protective value of iBALT within immunocompetent
hosts remains unclear, and in the context of our influenza
infection model, seems largely restricted to targeting the
viral nucleoprotein.
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